1. Home
  2. KTTA vs ARAI Comparison

KTTA vs ARAI Comparison

Compare KTTA & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.46

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Arrive AI Inc.

ARAI

Arrive AI Inc.

HOLD

Current Price

$0.37

Market Cap

20.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
ARAI
Founded
2020
2020
Country
United States
United States
Employees
5
51
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
20.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KTTA
ARAI
Price
$0.46
$0.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$12.00
AVG Volume (30 Days)
570.7K
491.8K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$800.66
Revenue Next Year
N/A
$650.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.36
52 Week High
$2.06
$12.85

Technical Indicators

Market Signals
Indicator
KTTA
ARAI
Relative Strength Index (RSI) 29.39 36.91
Support Level $0.28 $0.36
Resistance Level $0.86 $0.63
Average True Range (ATR) 0.05 0.04
MACD -0.00 0.01
Stochastic Oscillator 9.04 21.45

Price Performance

Historical Comparison
KTTA
ARAI

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: